AffiDX lateral flow test detects Delta Variant
LONDON, UK: Avacta Group plc announced that a study has shown that the AffiDX antigen lateral flow test detects the Delta variant of the SARS-CoV-2 virus in clinical samples and, in this small study, outperformed two lateral flow antigen tests…